title: [The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].
abstract: The authors describe regimens of Zofran application convenient in oncological practice to prevent nausea and vomiting in patients receiving cytostatic drugs. It is well tolerated and low toxic.
authors.forename: N I
authors.initials: NI
authors.lastname: Perevodchikova
authors.forename: M A
authors.initials: MA
authors.lastname: Volkova
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
authors.forename: L V
authors.initials: LV
authors.lastname: Manziuk
authors.forename: A F
authors.initials: AF
authors.lastname: Marenich
authors.forename: N B
authors.initials: NB
authors.lastname: Smirnova
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004341:Drug Evaluation; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D017294:Ondansetron / Q000008:administration & dosage*; D012702:Serotonin Antagonists / Q000008:administration & dosage*; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D012702:Serotonin Antagonists; D017294:Ondansetron
vernacular_title: Antagonist retseptorov 5HT3 zofran (ondansteron) kak sredstvo preduprezhdeniia toshnoty i rvoty pri tsitosticheskom lechenii onkologicheskikh bol'nykh.